How To Build A Hybrid Visit Strategy That Delivers High-Quality Results

By Helen Marks, Senior Project Manager, Site & Patient Services

In a Home Trial Support (HTS) model, clinical trials leverage the benefits of in-home and/or remote clinical visits for trial patients. With HTS, patients can avoid frequent travel to far-away clinical sites, minimize the need to set up childcare for in-person visits, and receive essential treatments from the comfort of their homes. Thanks to the convenience and accessibility of HTS, drug developers are seeing increased patient enrollment, engagement, and retention in their trials, which can help shorten their time to market.

Though the advantages of HTS are ample, many sponsors remain cautious about implementing home visits. For some sponsors, a traditional trial model seems like the safest route. Furthermore, clinical trial site teams may worry that hybrid trials could lead to reduced patient access or lost revenue. However, with proper protocol design and collaboration from an experienced HTS vendor, a hybrid trial can yield major benefits. Download the full article to learn more.